CF
Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
NYXH
301
Nyxoah
NYXH
$219M
|
RO
Ross Osborn
| $5.69 | $16 |
181%
upside
| Overweight |
5 Nov ‘24
10 months ago |
|
302
AbbVie
ABBV
$372B
|
LC
Louise Chen
| $210.42 | $240 |
14%
upside
| Overweight |
31 Oct ‘24
10 months ago |
|
303
Udemy
UDMY
$1.02B
|
BK
Brett Knoblauch
| $6.87 | $11 |
60%
upside
| Overweight |
30 Oct ‘24
10 months ago |
|
304
Harmony Biosciences
HRMY
$1.96B
|
CD
Charles Duncan
| $34 | $58 |
71%
upside
| Overweight |
30 Oct ‘24
10 months ago |
|
305
Fortinet
FTNT
$61.2B
|
YFL
Yi Fu Lee
| $79.84 | $88 |
10%
upside
| Neutral |
29 Oct ‘24
10 months ago |
|
306
Abeona Therapeutics
ABEO
$344M
|
KK
Kristen Kluska
| $6.83 | $18 |
164%
upside
| Overweight |
29 Oct ‘24
10 months ago |
|
307
Alkermes
ALKS
$4.7B
|
CD
Charles Duncan
| $27.85 | $43 |
54%
upside
| Overweight |
25 Oct ‘24
10 months ago |
|
308
Pfizer
PFE
$140B
|
LC
Louise Chen
| $24.71 | $45 |
82%
upside
| Overweight |
25 Oct ‘24
10 months ago |
|
309
Lam Research
LRCX
$134B
|
CJM
C J Muse
| $105.57 | $100 |
5%
downside
| Neutral |
24 Oct ‘24
10 months ago |
|
310
Texas Instruments
TXN
$168B
|
CJM
C J Muse
| $185.03 | $200 |
8%
upside
| Neutral |
23 Oct ‘24
10 months ago |
|
311
Regeneron Pharmaceuticals
REGN
$59B
|
OB
Olivia Brayer
| $556.53 | $1,015 |
82%
upside
| Neutral |
23 Oct ‘24
10 months ago |
|
312
Amgen
AMGN
$151B
|
OB
Olivia Brayer
| $279.97 | $405 |
45%
upside
| Overweight |
22 Oct ‘24
10 months ago |
|
313
Johnson & Johnson
JNJ
$426B
|
LC
Louise Chen
| $176.96 | $215 |
22%
upside
| Overweight |
16 Oct ‘24
10 months ago |
|
314
Alnylam Pharmaceuticals
ALNY
$63.2B
|
OB
Olivia Brayer
| $482.13 | $220 |
54%
downside
| Neutral |
11 Oct ‘24
11 months ago |
|
315
KLA
KLAC
$121B
|
CJM
C J Muse
| $917.73 | $925 |
1%
upside
| Neutral |
8 Oct ‘24
11 months ago |
|
316
Broadcom
AVGO
$1.58T
|
CJM
C J Muse
| $336.67 | $225 |
33%
downside
| Overweight |
8 Oct ‘24
11 months ago |
|
317
ARS Pharmaceuticals
SPRY
$1.06B
|
JS
Josh Schimmer
| $10.32 | $30 |
191%
upside
| Overweight |
8 Oct ‘24
11 months ago |
|
318
Surgery Partners
SGRY
$2.83B
|
SJ
Sarah James
| $21.94 | $43 |
96%
upside
| Overweight |
4 Oct ‘24
11 months ago |
|
|
BITF
319
Bitfarms
BITF
$879M
|
BK
Brett Knoblauch
| $1.59 | $5 |
214%
upside
| Overweight |
3 Oct ‘24
11 months ago |
|
320
Merck
MRK
$211B
|
LC
Louise Chen
| $84.61 | $155 |
83%
upside
| Overweight |
3 Oct ‘24
11 months ago |
|
321
Micron Technology
MU
$151B
|
CJM
C J Muse
| $135.24 | $150 |
11%
upside
| Overweight |
1 Oct ‘24
11 months ago |
|
322
GoDaddy
GDDY
$20.5B
|
DM
Deepak Mathivanan
| $148.88 | $170 |
14%
upside
| Neutral |
30 Sep ‘24
11 months ago |
|
323
Redwire
RDW
$1.18B
|
AS
Andres Sheppard
| $8.16 | $6 |
26%
downside
| Overweight |
30 Sep ‘24
11 months ago |
|
324
Skye Bioscience
SKYE
$128M
|
KK
Kristen Kluska
| $4.12 | $14 |
240%
upside
| Overweight |
20 Sep ‘24
11 months ago |
|
325
Humacyte
HUMA
$238M
|
KK
Kristen Kluska
| $1.50 | $13 |
767%
upside
| Overweight |
20 Sep ‘24
11 months ago |
|